A Pharmacokinetic (PK) Study of a Combination of Indinavir, Ritonavir, and Amprenavir
NCT00148785
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
Indinavir/Ritonavir/Fosamprenavir
Sponsor
Emory University